LEAP THERAPEUTICS INC. - COMMON STOCK

Leap Therapeutics Reports First Quarter 2018 Financial Results

11 May 2018 07:00:36 By Nasdaq GlobeNewswire

Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting

16 Apr 2018 09:00:32 By Nasdaq GlobeNewswire

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

27 Mar 2018 16:05:13 By Nasdaq GlobeNewswire

Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock

23 Mar 2018 09:00:30 By Nasdaq GlobeNewswire

Leap Therapeutics Announces Proposed Public Offering of Common Stock

22 Mar 2018 16:05:28 By Nasdaq GlobeNewswire

Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference

21 Mar 2018 07:00:33 By Nasdaq GlobeNewswire

Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting

14 Mar 2018 16:59:34 By Nasdaq GlobeNewswire

Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference

07 Mar 2018 07:01:09 By Nasdaq GlobeNewswire

Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Stockholders

23 Feb 2018 07:00:37 By Nasdaq GlobeNewswire

Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference

06 Feb 2018 07:00:45 By Nasdaq GlobeNewswire

Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors Trial

16 Jan 2018 07:00:26 By Nasdaq GlobeNewswire